Table 1

Baseline characteristics by trial arm status

CharacteristicsIntervention N=38Control N=33
Female patient, %5045
Age at registration, mean (SD)55.3 (12.4)57.8 (12.6)
White, %9693
Height in cm, mean (SD)167 (7)171 (8)
Weight in kg, mean (SD)95 (27)93 (27)
Time since diagnosis
 <5 years, %1915
 5–10 years, %238
 10–20 years, %2742
 20 years or more, %3135
Diagnosed by
 GP, %6976
 Consultant, %3124
Diabetes status
 Type I, %6173
 Type II, %3927
HbA1c, mean (SD)70.7 (17.1)68.2 (14.9)
ADDQoL—average weighted impact score, mean (SD)−1.6 (1.5)−2.8 (2.2)
Diabetes Empowerment Scale—short form, mean (SD)3.4 (0.6)3.6 (0.6)
DSCAQ—General Diet score, mean (SD)4.7 (2.1)4.5 (2.3)
DSCAQ—Specific Diet score, mean (SD)4.2 (1.6)4.4 (1.9)
DSCAQ—Exercise score, mean (SD)3.3 (2.4)3.0 (2.7)
DSCAQ—Blood Glucose Testing score, mean (SD)4.9 (2.4)5.9 (1.9)
DSCAQ—Foot Care score, mean (SD)2.9 (2.2)2.8 (2.4)
Diabetes Treatment Satisfaction Questionnaire score, mean (SD)27.7 (6.8)28.7 (6.0)
Patient Enablement Instrument, mean (SD)8.4 (4.0)7.2 (3.8)
Patient Report of Communication Behaviour, mean (SD)38.7 (8.0)39.3 (8.7)
  • Sample size ranges from 23 to 38 in the intervention arm and from 24 to 33 in the control arm.

  • ADDQoL, Audit of Diabetes-Dependent Quality of Life; GP, general practitioner; HbA1c, glycosylated haemoglobin.